Sir Brian Greenwood CBE, FRS, FMedSci
- Keppel Street
- WC1E 7HT
- T: + 44 20 7299 4712
- F: + 44 20 7299 4720
Professor of Clinical Tropical Medicine
DTM & M
I am involved in a number of studies on the control of malaria in Africa using drugs and vaccines. I am an investigator in the large phase 3 trial of the candidate malaria vaccine RTS,S/AS01 which is being undertaken at 11 centres in 7 countries in Africa. I am also an investigator in a study which is exploring ways of preventing malaria in pregnancy including a trial of screening women when they attend an antenatal clinic and treating just those who are positive for malaria as opposed to give antimalarials to all pregnant women without screening.
Meningococcal disease in Africa
The African Meningococcal Carriage Consortium (MenAfriCar) is evlauating the impact of a new serogroup A meningoccocal conjugate vaccine (MenAfriVac) on meningococcal menigitis and meningococcal carriage as this vaccine is roled out progressively across the African meningitis belt.
In The Gambia the impact of pneumococcal conjugate vaccines on invasive pneumococcal disease and pneumonia following their introduction into the routine ERPI programme is being investigated and a trial of a novel pneumococcal protein vaccine in infants is nearing completion.
Disease and Health Conditions
- Respiratory disease
- Sub-Saharan Africa (developing only)
- Burkina Faso
- Gambia, The
- United Kingdom
- capacity building